Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Audiocap connected hearing device to improve audibility in adults with hearing loss

Official title: Evaluation of Performances, Clinical Benefits and Safety of the 'Audiocap' Connected Hearing Rehabilitation Device for Improving Audibility in Hearing-impaired People in the Context of CE Marking

Run by Archean Technologies · NCT07252492 · Data updated 2026-11-12

This will see if the Audiocap connected hearing aid helps adults with mild-to-moderate hearing loss hear better than a placebo (flat-response) setting after one month.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment100 (estimated)
SponsorArchean Technologies
Industry-sponsored
Locations4 sites (Lyon, France and 3 other locations)
StatusRecruiting
StartedSeptember 10, 2025
Main results expectedSeptember 2027
Study endsSeptember 2027
Registry record updatedNovember 26, 2025
Trial IDNCT07252492 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) who are first-time hearing-aid users with mild-to-moderate adult-onset hearing loss meeting the listed audiological thresholds (for example 20–50 dB average or SRT >30 dB) are the intended participants.

Probably not a fit

People with severe or profound hearing loss, children, current or prior hearing-aid users, or those who do not meet the specified audiological thresholds are unlikely to benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The trial compares the Audiocap connected hearing aid to a placebo configuration (Audiocap set to a flat 'NONE' response equivalent to not wearing a hearing aid) to measure audiological gain after one month of use. Participants are adults who are first-time hearing-aid users and meet specific audiological thresholds for mild-to-moderate adult-onset hearing loss. The primary outcome is the change in audibility and speech understanding after one month of device use. The study is being conducted at clinical sites in Lyon and Paris in the context of CE marking for the device.

Why it matters

Potential benefit: If successful, Audiocap could provide first-time hearing-aid users clearer audibility and improved speech understanding in everyday situations.

How similar studies have gone: Conventional hearing aids and some connected devices have previously improved audibility in similar patients, but device-specific placebo-controlled comparisons for CE marking are relatively uncommon.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Subjects presenting one or more of the following criteria: a.Subject with mild to moderate hearing loss (20dB to 50dB average at 500, 1000, 2000, and 4000 Hz) in the better ear according to WHO standards, / b. Subject with a speech reception threshold (SRT) in quiet exceeding 30dB, corresponding to the minimum speech level required to achieve 50% recognition in silence (HAS eligibility criteria for hearing aid reimbursement), / c. Subject with significant degradation of speech intelligibility in noise, defined as a speech-to-noise ratio (SNR) deviation greater than 3dB compared to normative reference values (HAS eligibility criteria for hearing aid reimbursement), / d.Subject with high-frequency hearing loss greater than 30dB from 2000 Hz onwards, associated with a speech reception threshold exceeding 30dB in quiet and/or a significantly degraded speech intelligibility in noise (HAS eligibility criteria for hearing aid reimbursement).
2. Subjects eligible for first hearing aid.
3. Subjects over 18 years of age. French-speaking subjects.

5\. Subjects affiliated with a social security scheme. 6. Subjects who are not subject to another medical option, without external pathology and excluding implants.

7\. Subjects who have signed an informed consent. 8. Subjects available for the study.

Exclusion Criteria:

1. Subject deprived of his/her liberty by a judicial or administrative decision
2. Subject with severe psychiatric disorder
3. Subject admitted to a health or social care establishment
4. Subject not able to give consent
5. Adults under guardianship or trusteeship.
6. Subjects with disabling tinnitus that are not suitable for adaptation (THI\>56).
7. Subjects eligible for a cochlear implant.
8. Subjects not able to participate in the study according to the investigator.
9. Subjects with acute and chronic suppurative otitis media, congenital ear atresia, or any type of ear discharge.
10. Subjects with congenital atresia of external ear or deformity of any part of the ear canal.
11. Subjects with deafness that is unstable and with a degree of hearing loss often fluctuating.
12. Subjects with persistent headaches, dizziness, earaches, or other symptoms that are not suitable for adaptation.
13. Subjects with sudden onset of hearing loss within the past 3 months, rapid progressive deafness, unilateral hearing loss or other acute ear disease.
14. Subjects with effusion (secretions/ discharge) in the ear and/or frequent purulence (pus).
15. Subjects with central deafness (central nervous system) or non-organic deafness.
16. Subjects with acute otitis extrema and tympanitis.
17. Subjects who are allergic to materials of the device.

Where it's running

  • Clinique Rive-Gauche
    Toulouse, France, France
    Recruiting
  • Hôpital Edouard Herriot
    Lyon, France, France
    Not yet recruiting
  • Clinique de l'Oreille
    Paris, France, France
    Not yet recruiting
  • Hôpital Lariboisière (APHP)
    Paris, France, France
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • How hearing aids help in everyday noisy places

    This project tests whether different hearing aid settings and everyday noisy situations change how well hearing aids help adults with symmetric, adult-onset sensorineural hearing loss who already use hearing aids.

    Recruiting University of Wisconsin, Madison · Madison, Wisconsin · NCT07226167

  • Anatomy-Based Fitting for People with a Cochlear Implant and Hearing Aid

    This study tests whether an anatomy-based frequency distribution works better than the default one for adults with a cochlear implant and a contralateral hearing aid.

    Recruiting at 2 sites Universitair Ziekenhuis Brussel · Antwerp and 1 other locations · NCT07691853

  • Evaluating remote fine-tuning of hearing aids for Danish adults

    This study is testing if adjusting hearing aids through a smartphone app at home is just as effective and satisfying for Danish adults as getting adjustments in person at a clinic.

    Recruiting Zealand University Hospital · Køge · NCT06992778

  • Understanding how cochlear implant users hear speech in noise

    This study is trying to see how cochlear implant users hear speech in noisy places by looking at their brain activity compared to people with normal hearing.

    Recruiting University of Iowa · Iowa City, Iowa · NCT06860152

  • AirPods Pro as hearing assistive technology

    This test will see if AirPods Pro help adults with mild-to-moderate hearing loss understand speech in noisy places compared with hearing aids and wireless remote microphones.

    Recruiting The University of Texas at Dallas · Richardson, Texas · NCT06840015

  • Investigating cognitive function changes in older adults with hearing loss using hearing aids

    This study is testing if using hearing aids can help older adults with hearing loss think better and lower their chances of developing dementia.

    Recruiting Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Guangzhou, Guangdong · NCT05694039

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.